Laurence Reid Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Laurence Reid.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Laurence Reid. Laurence Reid is SVP and Chief Business Officer in ALNYLAM PHARMACEUTICALS, INC. ($ALNY) and SVP, Chief Business Officer in ALNYLAM PHARMACEUTICALS, INC. ($ALNY).
Latest Insider Trading Transactions of Laurence Reid
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Option Exercise | A | 63.00 | 6,667 | 420,021 | 6,667 | |
May 21 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Option Exercise | M | 9.14 | 11,000 | 100,540 | 16,589 | |
May 21 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Option Exercise | M | 7.10 | 2,500 | 17,750 | 17,500 | |
May 21 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Sell | S | 58.01 | 10,900 | 632,310 | 3,905 | 14.8 K to 3.9 K (-73.62 %) |
May 21 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Sell | S | 57.07 | 2,600 | 148,374 | 14,805 | 17.4 K to 14.8 K (-14.94 %) |
May 21 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Buy | M | 9.14 | 11,000 | 100,540 | 17,405 | 6.4 K to 17.4 K (+171.74 %) |
May 21 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Buy | M | 7.10 | 2,500 | 17,750 | 6,405 | 3.9 K to 6.4 K (+64.02 %) |
Feb 20 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Option Exercise | M | 15.99 | 3,500 | 55,965 | 154,248 | |
Feb 20 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Option Exercise | M | 7.10 | 10,000 | 71,000 | 20,000 | |
Feb 20 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Sell | S | 81.45 | 400 | 32,579 | 3,905 | 4.3 K to 3.9 K (-9.29 %) |
Feb 20 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Sell | S | 80.85 | 5,456 | 441,120 | 4,305 | 9.8 K to 4.3 K (-55.90 %) |
Feb 20 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Sell | S | 80.02 | 11,465 | 917,469 | 9,761 | 21.2 K to 9.8 K (-54.01 %) |
Feb 20 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Sell | S | 78.62 | 3,079 | 242,071 | 21,226 | 24.3 K to 21.2 K (-12.67 %) |
Feb 20 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Buy | M | 15.99 | 3,500 | 55,965 | 24,305 | 20.8 K to 24.3 K (+16.82 %) |
Feb 20 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Buy | M | 7.10 | 10,000 | 71,000 | 20,805 | 10.8 K to 20.8 K (+92.55 %) |
Jan 27 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Payment of Exercise | F | 89.49 | 3,698 | 330,934 | 10,805 | 14.5 K to 10.8 K (-25.50 %) |
Jan 02 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Option Exercise | M | 15.99 | 3,752 | 59,994 | 157,748 | |
Jan 02 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Payment of Exercise | F | 64.51 | 930 | 59,994 | 14,503 | 15.4 K to 14.5 K (-6.03 %) |
Jan 02 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Buy | M | 15.99 | 3,752 | 59,994 | 15,433 | 11.7 K to 15.4 K (+32.12 %) |
Dec 18 2013 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Option Exercise | A | 63.00 | 20,000 | 1,260,000 | 20,000 | |
Nov 15 2013 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Option Exercise | M | 15.99 | 13,500 | 215,865 | 161,500 | |
Nov 15 2013 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Sell | S | 53.36 | 13,500 | 720,302 | 11,681 | 25.2 K to 11.7 K (-53.61 %) |
Nov 15 2013 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Buy | M | 15.99 | 13,500 | 215,865 | 25,181 | 11.7 K to 25.2 K (+115.57 %) |
May 30 2013 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP and Chief Busin ... | Option Exercise | M | 7.10 | 5,000 | 35,500 | 30,000 | |
May 30 2013 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP and Chief Busin ... | Sell | S | 30.00 | 5,000 | 150,000 | 11,681 | 16.7 K to 11.7 K (-29.97 %) |
May 30 2013 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP and Chief Busin ... | Buy | M | 7.10 | 5,000 | 35,500 | 16,681 | 11.7 K to 16.7 K (+42.80 %) |
Feb 12 2013 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Option Exercise | M | 7.10 | 5,000 | 35,500 | 35,000 | |
Feb 12 2013 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Sell | S | 25.00 | 5,000 | 125,000 | 11,681 | 16.7 K to 11.7 K (-29.97 %) |
Feb 12 2013 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Buy | M | 7.10 | 5,000 | 35,500 | 16,681 | 11.7 K to 16.7 K (+42.80 %) |
Dec 21 2012 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Option Exercise | A | 18.66 | 40,000 | 746,400 | 40,000 | |
Feb 23 2012 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Buy | P | 10.75 | 930 | 9,998 | 11,681 | 10.8 K to 11.7 K (+8.65 %) |
Jan 25 2012 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Grant | A | 0.00 | 10,751 | 0 | 10,751 | 0 to 10.8 K |
Dec 02 2011 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Option Exercise | A | 7.10 | 40,000 | 284,000 | 40,000 | |
Dec 10 2010 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Option Exercise | A | 9.14 | 27,589 | 252,163 | 27,589 | |
Jun 03 2010 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Option Exercise | A | 15.40 | 175,000 | 2,695,000 | 175,000 |
Page: 1